Treatment of hairy cell leukaemia (HCL) with 2-chlorodeoxyadenosine (2- CdA): Identification of parameters predictive of adverse effects

British Journal of Haematology

Volumn 99, Issue 1, 1997, Pages 165-167

  Legrand, Ollivier ^a   Vekhoff, Anne ^a   Marie, Jean Pierre ^a   Zittoun, Robert ^a   Delmer, Alain ^a  

^a HÔTEL DIEU   (France)

Author keywords

2 CdA; Adverse effects; Hairy cell leukaemia; Interferon alpha; Prognostic factors

Indexed keywords

ALPHA INTERFERON; CLADRIBINE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HAIRY CELL LEUKEMIA; HUMAN; LEUKEMIA REMISSION; MALE; NEUTROPENIA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTOPENIA;

EID: 0030778234     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.3483162.x     Document Type: Article

References (11)

1. Anchisi, S., Zulian, G.B., Dietrich, P.Y. & Alberto, P (1995) Claridrine and tumor lysis syndrome. European Journal of Cancer, 31A, 131-132.
2. Betticher, D.C., Fey, M.F., Rabaglio, M., Cerny, T., Hess, U., Meier, V. Stadler, M. & Zulian, G. (1993) Cladribine and severe myelotoxicity. Lancet, 342, 1369.
3. Cheson, B.D., Vena, D.A., Foss, F.M. & Sorensen, J.M. (1994) Neurotoxicity of purine analogs: a review. Journal of Clinical Oncology, 12, 2216-2228.
4. Estey, E.H., Kurzrock, R., Kantarjian, H.M., O'Brien, S.M., McCredie, K.B., Beran, M., Koller, C., Keating, M.J., Hirsch-Ginsberg, C., Huh, Y.O., Stass, S. & Freireich, E. (1992) Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Blood, 79, 882-887.
5. Glaspy, J.A., Souza, L., Scates, S., Narachi, M., Blatt, L., Ambersley, J. & Golde, D.W. (1992) Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b. Journal of Immunotherapy, 11, 198-202.
6. Grever, M., Kopecky, K., Foucar, M.K., Head, D., Bennet, J.M., Huthchison, R.E., Corbett, W.E.N., Cassileth, P.A., Habermann, T., Colomb, H., Rai, K., Eisenhauer, E., Appelbaum, F. & Cheson, B.D. (1995) Randomized comparison of pentostatine versus Interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study. Journal of Clinical Oncology, 13, 974-982.
7. Piro, L.D., Carrera, C.J., Carson, D.A. & Beutler, J.E. (1990) Lasting remission in hairy-cell leukemia induced by a single infusion of 2-chloroadeoxyadenosine. New England Journal of Medicine, 322, 1117-1121.
8. Quesada, J.R., Reuben, J., Manning, J.T., Hersh, E.M. & Gutterman, J.M. (1984) Alpha interferon for induction of remission in hairy cell leukemia. New England Journal of Medicine, 310, 15-18.
9. Smith, J.W., II, Longo, D.L., Urba, W.J., Clark, J.W., Watson, T., Beveridge, J., Conlon, K.C., Sznol, M., Creekmore, S.P., Alvord, W.G., Lawrence, J.B. & Steis, R.G. (1991) Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alfa 2a. Blood, 78, 1664-1671.
10. Spiers, A.S.D., Moore, D., Cassileth, P.A., Harringhton, D.P., Cummings, F.J., Neiman, R.S., Bennett, J.M. & O'Connel, M.J. (1987) Remission in hairy-cell leukemia with pentostatin (2′-deoxycoformycin). New England Journal of Medicine, 316, 825-830.
11. Tallman, M.S., Hakimian, D., Rademaker, A.W., Zanzig, C., Wollins, E., Rose, E. & Peterson, L.A. (1996) Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience. Blood, 88, 1954-1959.